We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-15.3%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$20B
AUM Growth
-$4.58B
Cap. Flow
-$205M
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.75%
Holding
1,300
New
139
Increased
450
Reduced
467
Closed
138

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$62M
2
AAPL icon
Apple
AAPL
+$59.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$42M
4
ADBE icon
Adobe
ADBE
+$38.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$38.2M

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$58.6M
2
V icon
Visa
V
+$48.9M
3
CHTR icon
Charter Communications
CHTR
+$44.5M
4
KKR icon
KKR & Co
KKR
+$43.8M
5
FIS icon
Fidelity National Information Services
FIS
+$37.8M

Sector Composition

Rank Sector Weight
1 Technology 26.35%
2 Healthcare 19.06%
3 Financials 10.37%
4 Consumer Discretionary 10.34%
5 Industrials 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
1101
Akebia Therapeutics
AKBA
$338M
$136K ﹤0.01%
+18,000
New +$140K
CYD icon
1102
China Yuchai International
CYD
$1.69B
$130K ﹤0.01%
12,100
-589
-5% -$7.06K
TIMB icon
1103
TIM SA
TIMB
$9.1B
$130K ﹤0.01%
10,660
RRR icon
1104
Red Rock Resorts
RRR
$3.84B
$129K ﹤0.01%
15,100
-41,700
-73% -$827K
SRNE
1105
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$126K ﹤0.01%
68,600
LFVN icon
1106
LifeVantage
LFVN
$80.1M
$117K ﹤0.01%
11,337
DVN icon
1107
Devon Energy
DVN
$51.3B
$107K ﹤0.01%
15,506
+4,163
+37% +$75.3K
BMY.RT
1108
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$107K ﹤0.01%
28,235
-1,197
-4% -$3.94K
SNCR
1109
DELISTED
Synchronoss Technologies
SNCR
$105K ﹤0.01%
3,822
-11,145
-74% -$491K
VYGR icon
1110
Voyager Therapeutics
VYGR
$181M
$105K ﹤0.01%
11,500
+600
+6% +$6.89K
LPG icon
1111
Dorian LPG
LPG
$1.96B
$104K ﹤0.01%
+11,900
New +$141K
BBBY
1112
Bed Bath & Beyond
BBBY
$479M
$103K ﹤0.01%
24,984
-5,626
-18% -$30.6K
PCOM
1113
DELISTED
Points.com Inc. Common Shares
PCOM
$103K ﹤0.01%
12,500
NOV icon
1114
NOV
NOV
$6.84B
$99K ﹤0.01%
10,097
-496
-5% -$9.35K
CTT
1115
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$92K ﹤0.01%
+12,800
New +$123K
AVID
1116
DELISTED
Avid Technology Inc
AVID
$86K ﹤0.01%
12,800
-9,600
-43% -$75.8K
CVE icon
1117
Cenovus Energy
CVE
$54.2B
$79K ﹤0.01%
39,239
+12,725
+48% +$89.2K
GES
1118
DELISTED
Guess Inc
GES
$79K ﹤0.01%
11,700
-196,900
-94% -$3.43M
UGP icon
1119
Ultrapar
UGP
$6.66B
$78K ﹤0.01%
32,170
-2,764
-8% -$13.3K
REZI icon
1120
Resideo Technologies
REZI
$5.4B
$76K ﹤0.01%
15,661
-37,508
-71% -$354K
PTEN icon
1121
Patterson-UTI
PTEN
$3.54B
$72K ﹤0.01%
30,600
-563,400
-95% -$3.65M
CBIO
1122
Crescent Biopharma
CBIO
$546M
$70K ﹤0.01%
306
-9,146
-97% -$3.5M
ATEN icon
1123
A10 Networks
ATEN
$2.07B
$65K ﹤0.01%
+10,400
New +$66.5K
APA icon
1124
APA Corp
APA
$13B
$63K ﹤0.01%
15,190
-22,954
-60% -$512K
MUR icon
1125
Murphy Oil
MUR
$5.55B
$62K ﹤0.01%
+10,100
New +$186K

Similar funds

Axa's Q1 2020 Portfolio in Review

As of Q1 2020, Axa held 1,300 positions worth $20B, down 19% from $24.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q1 2020 filing shows 139 new, 450 increased, 467 reduced and 138 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 924,400 shares worth $23.5M. The largest sale was eBay, an estimated $58.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q1 2020 buy was Axonics, Inc. Common Stock: 924,400 shares worth $23.5M.
  • Axa added most to Alphabet (Google) Class A in Q1 2020, an estimated $62M increase.
  • Axa's biggest Q1 2020 reduction was eBay, cutting an estimated $58.6M.
  • Axa fully exited KKR & Co in Q1 2020, selling an estimated $43.8M.
  • Axa's ten largest holdings make up 19% of its $20B portfolio in Q1 2020.
  • Axa opened 139 new positions and closed 138 in Q1 2020.
  • Axa's portfolio value fell 19% quarter-over-quarter to $20B.

Based on Axa's 13F filing for Q1 2020, filed 15 May 2020.